Cargando…
Bone Metastasis in Bladder Cancer
Bladder cancer (BCa) is the 10th most common and 13th most deadly malignancy worldwide. About 5% of BCa patients present initially with metastatic disease, with bone being the most diagnosed site for distant metastasis. The overall one-year survival of patients with BCa is 84%, whereas it is only 21...
Autores principales: | Yi, Lei, Ai, Kai, Li, Xurui, Li, Zhihong, Li, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864951/ https://www.ncbi.nlm.nih.gov/pubmed/36675715 http://dx.doi.org/10.3390/jpm13010054 |
Ejemplares similares
-
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021) -
Advances in cancer pain from bone metastasis
por: Zhu, Xiao-Cui, et al.
Publicado: (2015) -
Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer
por: Zhou, Keqin, et al.
Publicado: (2019) -
Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis
por: Zhu, Mingyu, et al.
Publicado: (2019) -
Roles of calcium signaling in cancer metastasis to bone
por: Xie, Tianying, et al.
Publicado: (2022)